A Study of 2 Doses of MAP0010 in Asthmatic Children

This study has been terminated.
(Corporate decision)
Sponsor:
Information provided by:
MAP Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00697697
First received: June 12, 2008
Last updated: November 13, 2009
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)